When physicians regularly exhibit a lack of civility and respect, patient safety and quality of care are compromised.
19 min.

CHICAGO (January 14, 2020) — The Society of Thoracic Surgeons (STS) has been monitoring with keen interest the controversy in the medical literature and the lay press regarding recently published studies evaluating results of coronary artery bypass grafting (CABG) and percutaneous coronary interventions (PCI) in patients with left main disease. 

Jan 14, 2020
Jan 3, 2020
1 min read
Monisha Sudarshan, MD, MPH, FRCSC
Jan 3, 2020
1 min read
Steven Bolling, MD
Jan 2, 2020
1 min read
Image
Career Development Blog
On the surface, cardiothoracic surgeons are the embodiments of resilience. But how easily do we really bounce back from the inevitable catastrophes?
4 min read
Melanie A. Edwards, MD
Image
In the News: A Surgeon's View
Dr. Thomas E. MacGillivray explains how the ISCHEMIA trial does not negate or even contradict the multiple previous clinical trials demonstrating the superiority of surgical revascularization over medical therapy (or PCI) in patients with specific anatomic patterns of coronary artery disease.
5 min read
Thomas E. MacGillivray, MD